To confer adenovirus vectors (AdV), the feature of integration into the host cell genome hybrid vectors were characterized in vitro, which express vectors derived from the prototypic foamy virus (FV) in the backbone of a highcapacity AdV. FVs constitute a subfamily of retroviruses with a distinct replication pathway and no known pathogenicity. In the absence of envelope glycoprotein, the prototypic FV behaves like a retrotransposon, while it behaves like an exogenous retrovirus in its presence. Two principle types of vectors, which either allows the intracellular (HC-FAD-7) or, in addition, the extracellular (HC-FAD-2) pathway were constructed. In both chimeras the expression of the FV vector was controlled by the tetracycline-regulatable system.
Introduction
Adenovirus vectors (AdVs) are widely used in experimental gene transfer and human clinical gene therapy trials. 1, 2 The advantages of Ad-derived compared to other viral vectors reside in the high titers to which they can be produced and the often high transduction efficiency of resting and dividing target cells of different origin both in vitro and in vivo. The disadvantages of the first-generation AdV, such as a packaging capacity limit for foreign DNA of approximately 8 kb and immunogenicity and toxicity could be overcome, in part, with the development of high-capacity 'gutless' Advs (HC-AdV). 3 In addition, the duration of expression following HCAdV-mediated expression in vivo is prolonged compared to that of the first-generation vectors. 4, 5 However, since the vector genome does not integrate into the host cell genome, gene expression is transient in dividing cells.
Among integrating vectors, those derived from retroviruses are by far most common. Retroviral vectors can be easily produced and their molecular biology is well understood. However, the titers of retroviral vectors (RVs) are frequently too low for in vivo applications. 1, 2 The family of Retroviridae is divided into the subfamilies of orthoretroviruses (ORVs) and spumaretroviruses or foamy viruses (FVs). 6 FVs are a group of apparently nonpathogenic nonhuman retroviruses, which follow a unique replication pathway; 7, 8 with all other retroviruses they share integration into the host cell genome. 8 While vectors derived from ORV have been known for more than 20 years, FV vectors have been developed only recently. 9, 10 One particular feature of the prototypic FV (PFV) has been described recently as an intracellular retrotransposition (IRT). PFV-specific IRT has been shown to consist of the conversion of an RNA pregenome into an integration-competent cDNA copy without the generation of an infectious extracellular virus. 11 PFV-specific IRT depends on functionally active Gag and Pol proteins. 11 The efficiency of PFV IRT was found to be in the percentage range, which is far above any mammalian retrotransposon. 11 We therefore wished to characterize hybrids between the nonintegrating high-capacity Adand PFV-derived vectors to investigate the possibility of establishing prototype hybrid vectors that combine the features of a high titer production and persistence. To this end, we attempted to exploit the extracellular as well as the intracellular replication pathway of PFV.
In pFAD-2, a complete expression cassette for PFV gene products necessary to generate an infectious extracellular particle (gag, pol, and env) was incorporated ( Figure 1 ). However, only one round of PFV replication can be performed by pFAD-2, because the PFV genome lacks the transcriptional transactivator gene (tas), which is strictly required for autonomous replication. 12 Furthermore, the 3 0 U3 region of the long terminal repeat (LTR) was deleted in the DNA-binding sites of the Tas protein and the core promoter sequences. 13 In the absence of Tas no gene expression can be detected even from an undeleted LTR. 14, 15 The PFV vector genome was placed under transcriptional control of an inducible tetracycline-dependent promoter, and an expression cassette for the reverse tetracycline-dependent transactivator was also incorporated into pFAD-2. To monitor gene transfer, we included the gene for enhanced green fluorescent protein under constitutive transcriptional control of the spleen focus-forming virus (SFFV) U3 promoter ( Figure 1 ). This promoter is not controlled by the tetracycline system.
The other type of hybrid vector is represented by pFAD-7 ( Figure 1 ). In contrast to the first vector type, pFAD-7 lacks the PFV env gene, which is required for viral capsid export. 16, 17 The PFV part of pFAD-7 can only perform an intracellular replication cycle, that is, retrotranspose the PFV genome into that of the host cell. Since we expected the efficiency of stable marker gene transduction by pFAD-7 to be far less compared with pFAD-2, 11 we also generated a negative control, pFAD-8 ( Figure 1) , in which the translational start codon of the pol gene was mutated from ATG to CTG. In contrast to ORVs, in spumaretroviruses, the Pol protein is not expressed as a fusion product with the Gag capsid protein, but independently of a spliced pol RNA. 18 Therefore, the mutation of the pol gene ATG does not allow the expression of a functional Pol protein. 19 The control of gene expression in pFAD-7 and -8 and the internal marker gene cassette were identical to pFAD-2 ( Figure 1 ). After the generation of the constructs shown in Figure 1 , the corresponding final FAD vectors were generated by insertion into the HC-AdV plasmid backbones pSTK68 (for pFAD-2) or pSTK134 (for pFAD-7 and -8). The hybrid vectors were generated to titers of approximately 8 Â 10 9 infectious HC-Ad particles/ml 20 and the vector genomes were characterized by restriction enzyme analysis for integrity (data not shown).
The ways in which HC-FAD-2 and -7 were expected to transduce recipient cells is illustrated in Figure 2 . After the transduction of cells with HC-FAD vectors, transient gene expression is induced with tetracycline. In the case of the HC-FAD-7 this should lead to the expression of capsid (Gag) and Pol proteins, which package and reverse transcribe an RNA pregenome. Following recycling to the host cell nucleus the integration and stable expression of the EGFP marker gene occurs; however, no further gene expression of PFV proteins. In case of the negative controls, HC-FAD-8 and HC-AdFK7, which is an HC-AdV-expressing EGFP under constitutive control of the CMV promoter, 21 we expected marker gene expression to be transient. In case of the HC-FAD-2 vector a different scenario was envisioned. The coexpression of Env protein should lead to PFV vector particle export from primarily transduced cells. Secondary cells could then be stably transduced after which PFV expression should cease.
A549 cells were transduced in duplicate with the vectors at an MOI of 100 and PFV gene expression was induced with doxycycline for 2 days in half of the cultures. Thereafter, cellular lysates were prepared and analyzed by immunoblot for the expression of PFV proteins. As shown in Figure 3 , all the expected PFV proteins were expressed from the HC-FAD vectors. p71/ 68
Gag is the capsid protein doublet characteristic of PFV. 22 It was detectable in HC-FAD-2-and HC-FAD-7-transduced cells (Figure 3a) . In HC-FAD-8-transduced cells only the pr71 Gag precursor was stained, because p68 Gag is derived from protease-mediated cleavage of pr71 HC-FAD-7 is only able to perform the internal retrotransposition pathway of cells initially transduced by the hybrid vector. This pathway includes cytoplasmic particle assembly and reverse transcription of the PFV vector, which is followed by the nuclear entry and integration into the host cell genome (step 4). This leads to the stable expression of the EGFP marker (step 5). Owing to Env expression HC-FAD-2 can generate extracellular PFV vector particles (step 6). These are infectious only for one further round and able to transduce other cells (step 7). In the second round, transduced cells the PFV vector integrates into the host cells genome (step 8), which leads to stable EGFP transgene expression (step 9).
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protease, however, is encoded in the pol open-reading frame, which was disabled in HC-FAD-8 ( Figure 1 ). The expression of Pol and Env proteins is shown in Figure 3b . The gp130 Env precursor and the gp18 Env leader peptide (LP) were detected in HC-FAD-2-transduced cells, 23 and the full-length Pol proteins in cells transduced with HC-FAD-2 and -7. In HC-FAD-8-transduced cells, a minor band migrating below the p127 Pol precursor was found. This band probably corresponds to a Pol protein that was initiated at an internal methionine codon.
The control of expression by tetracycline was found to be somewhat leaky, because the characteristic capsid protein doublet was visible in HC-FAD-7-transduced cells also in the uninduced state even in immunoblots with reduced amounts of proteins loaded onto the gels (Figure 3a) . 

Analysis of transduced cell clones
Single-cell clones were established from HC-FAD-2-and HC-FAD-7-transduced and marker-positive cells following single-cell sorting. DNA was harvested from the cell clones and analyzed by Southern blot for PFV vector genome integrants. As shown in Figure 5a and b, the probe detects a fragment of PFV gag/pol. All hybridizing bands larger than 5.4 kb represent random integration products. 11 While some single-cell clones, such as #2, #3, and #5 of HC-FAD-7-transduced cells (Figure 5d ), harbored only one or two integrants, in the majority of cases multiple proviruses were found (Figure 5c and d) . When the vector DNAs were analyzed with the same probe only single bands of different sizes compared with those of the cell clones were detected (Figure 5c and d, lane CC, Figure 5e ). In addition, when the DNA of the stably transduced cell clones was probed with labeled HC-AdV ITR DNA no signal was visible, although we were able to detect 48 pg of vector DNA in a background of 10 mg cellular DNA, which corresponds to one copy of vector DNA per cellular genome. The latter two experiments provide evidence that not an integration by chance of the HC-Ad vector genome 24 was responsible for the stable transduction of cells by HC-FAD-2 and -7.
To analyze the integrity of the PFV vector cassette following integration, we performed a Southern blot hybridization of DNA after restriction with an enzyme that cuts twice in the PFV vector genome. As shown in Figure 6 , the internal NcoI fragment was readily detected in all single-cell clones obtained following transduction with HC-FAD-2 or -7.
In the HC-FAD hybrid vectors, the PFV vector part is under transcriptional control of the tetracycline-inducible promoter. Upon reverse transcription, the Tet promoter is lost and the 3 0 PFV U3 region from the LTR is transferred to the 5 0 end of the vector genome. To demonstrate successful reverse transcription of the PFV vector part, we also hybridized DNA to an internal fragment reaching from the 5 0 U3 region into the gag gene. As shown in Figure 7 , the indicative band was found in DNA from HC-FAD-2-and HC-FAD-7-transduced cells, but was absent from the hybrid vector. Furthermore, we generated a similar result when the DNA was analyzed by PCR with primers specifically amplifying a 5 0 U3-gag gene fragment (data not shown).
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Discussion
Hybrid vectors, which combine the ability to be produced to high titers and efficiency to transduce recipient cells of AdV with the stability of gene 
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expression provided by integrating vectors have already been reported in the past. [24] [25] [26] [27] [28] These hybrids are based on either of the two principles: vectors, which harbor a transposable element to enhance the frequency of stable gene expression in the cells transduced by the AdV, and vectors, which produce the RV, which in turn stably transduces cells in a secondary round of infection.
The HC-FAD-7 vector described in this study falls in the first category. As other previously described hybrid vectors of this type, it can be produced to high titer and the frequency of stable integration is clearly detectable but low. 24 We believe the stable transduction frequencies by the currently available hybrid vectors of this type to be too low to exhibit substantial benefit in an in vivo application. However, we want to point out that the exact frequency and function of PFV IRT is not known yet.
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Further studies into this direction may uncover new viral or cellular principles, which enable PFV IRT to be upregulated.
The other category of hybrid vectors is exemplified by HC-FAD-2. It can also be produced to a high titer of close to 10 10 infectious Ad particles/ml that would allow an in vivo application. Compared to HC-FAD-7, the HC-FAD-2 vector has a very high stable transduction efficiency of over 80% in cell culture when the cells were transduced at an MOI of 100. The HC-FAD-2 vector has several advantages over other AdV-RV hybrid vectors described previously. 24 First, the use of the high-capacity backbone enabled the insertion of the complete PFV cassette into one AdV. This eliminated the requirement to hit one primary target cell by two AdVs to create an RV packaging cell line. [25] [26] [27] Furthermore, such a procedure inherently bears the risk of generating the replicationcompetent helper virus. Second, although the PFV receptor is still unknown, cells that resist FV infection at the receptor level to our knowledge do not exist. 29 Thus, the spectrum of cells, which can be transduced in a second round by the HC-FAD-2 vector is very broad and includes primary human cells. 30, 31 Third, infections by FVs of natural hosts, immunocompetent laboratory animals, and accidentally infected humans are nonpathogenic. 32, 33 This is in sharp contrast to other retroviruses and a prime reason to continue with the development of FV vectors. Fourth, the authentic PFV promoter essentially requires the Tas transcriptional transactivator for the activity. 14, 15 Therefore, the deletion of the tas gene and of its response elements in the LTR is a further safety feature and enables to direct the expression of the foreign gene(s) by any kind of desired internal promoter.
Here, we described the establishment of a prototype hybrid vector. One may think of several improvements of HC-FAD-2: (i) PFV vectors have been improved recently when separate expression cassettes for the structural genes, which are required to package the vector, and for the vector proper became available. 9, 10 This minimizes the risk of copackaging nonvector RNA. The HC-AdV can easily accommodate these separate expression cassettes.
(ii) The introduction of more stringent inducible and/or tissue-specific promoter systems will further enhance the safety and the specificity of the HC-FAD vector system.
Materials and methods
Recombinant DNA
Established methods in molecular biology were used for manipulating recombinant DNA. 34, 35 The high-capacity AdV plasmids pSTK68 and pSTK134, 3 the recombinant HC-AdFK7, 21 the PFV vectors pMH88 and pMH89, 36 pUHG17-1 that encodes the rTA HSV-VP16 fusion gene under transcriptional control of the CMV immediateearly gene promoter, 37 and the respective promoter plasmid pUHD10-3, which contains seven binding sites for rTA and a minimal CMV promoter sequence of 55 nucleotides 38 have been described previously. The PFV vector pMH87 is structurally identical to pMH88 except that it contains the PFV env gene in its authentic position in addition to the gag and pol genes. pTJ-12 was carried out by inserting a pMH88-derived PCR amplimer, which runs from an StuI site in the CMV promoter to an EcoRV site in the gag gene and which was generated with oligonucleotide primers #327 (5 0 -GTT ACT GGT CTG TAA GAA CTA C) and #439 (5 0 -TGG GAG GCC TAT ATA AGC AGA GCT G), into StuI/HpaI-cleaved pUHD10-3. pTJ-13 was constructed by inserting a 0.3 kb Bsp120I/PvuII pcDNA-derived (Invitrogen) fragment, which contains the bovine growth hormone polyA þ signal sequence, into BamHI-cleaved and Klenow enzyme-treated pUHG17-1 downstream of the rTA gene. This leads to the restoration of the 3 0 BamHI site. The insertion of a 0.7 kb XhoI(blunted)/EheI pTJ-12 fragment into MluI(blunted)/EheI-cleaved pMH88 generated pTJ-14. pTJ15 was carried out by the insertion of a blunted 2.1 kb pTJ-13 XhoI/BamHI fragment, which harbors the rTA expression cassette, into Eco47III-cleaved pTJ-14. The PFV pol gene ATG to CTG mutant pMH127 was derived by ligating 12.7 kb pTJ-15 with 1.8kb pMH89 PacI/SwaI-cleaved fragments. pMH126 was carried out by ligating 11.4 kb pTJ-15 with 6.0 kb HC-FAD vector M Picard-Maureau et al pMH87 PacI/NotI-cleaved fragments. Finally, the hybrid vectors pFAD-2, -7, and -8 were constructed by inserting 13.2 kb pMH126 and 10.4 kb pTJ-15 and pMH127 PmeI fragments into BamHI-or NotI-opened and Klenow enzyme-treated pSTK68 and pSTK134 AdV plasmids, respectively. All FAD vectors bear an internal EGFP expression cassette under transcriptional control of the SFFV U3 region. 36 
Propagation of HC-FAD vectors and transduction experiments
The HC-FAD vectors were propagated as described with slight modifications. The corresponding plasmids were liberated from bacterial control sequences by restriction with PmeI. The 293-cre66 cells (G Schiedner, unpublished) were infected with the helper virus HC-AdLC8cluc 39 and transfected with linear vector backbones using calcium phosphate co-precipitation 4-5 h later. The vectors were serially amplified in 293-cre66 cells and purified as described. 5 The titers of the vector preparations were determined by a slot blot procedure. 20 Cells were transduced with vectors and monitored for EGFP expression by flow cytometry as detailed elsewhere. 9 Transcription of the PFV vector was induced with 1 mg/ml doxycycline. Single-cell clones were established following cell sorting in a FACSvantage (Becton Dickinson).
Protein detection
Lysates were prepared from cells transduced with recombinant vectors by resolving in SDS-containing buffer. 22 Following centrifugation through the Qiashredder (Qiagen) to destroy high molecular weight (MW) nucleic acids, the proteins were separated in 7.5% polyacrylamide gels (SDS-PAGE) in a tricine buffer system. After blotting, the gels were reacted with mouse monoclonal antibodies (MABs) against PFV Gag and Pol proteins, 9,40,41 a rabbit antiserum against the PFV Env LP, 23 or with an MAB against human b-actin (Sigma). Following treatment with secondary antibodies (DAKO), the immunostain was developed using the ECL detection system (Amersham).
Southern blot analysis
High MW DNA from vector-transduced cells and viral DNA from purified HC-AdV were prepared after lysis with SDS and proteinase K digestion by the established methods. 34, 35 After overnight restriction with appropriate enzymes and separation in agarose gels, the DNAs were blotted onto nylon membranes, hybridized to randomly labeled probes, washed and exposed to X-ray films using high-stringency conditions. 34, 35 
